Evidence map›Paper›PMID 40301882›Full record

ArticleBMC health services research2025

Impact of digital integrated health platforms on diabetes management: evidence from Tianjin, China.

Zhaoqi Xu, Xiaoyu Xi, Ennan Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Observational
  3. Tubeless Insulin Pump Combined with a Cloud-Based Data Management Platform: Real-World Evidence from 14,765 French People with Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhaoqi XuSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, China.
Xiaoyu XiSchool of International Pharmaceutical Business, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, Jiangsu, China. cpuxixiaoyu@163.com.
Ennan WangSchool of Health Policy & Management, Nanjing Medical University, 101 Longmian Avenue, Nanjing, Jiangsu, China. wen@njmu.edu.cn.

Funding

National Science Foundation of China 72404141the Ministry of education of Humanities and Social Science Project 23YJCZH204the Philosophy and Social Science Project for the University by Jiangsu Education Department 2023SJYB0297
6 · The paper itself

Abstract

objectiveEvaluate the impact of digital integrated health platforms on diabetes patients' health in Tianjin.

methodAnalyzed data from 2,883 patients under Tianjin's digital integrated health platform using descriptive statistics and Probit regression.

resultsChronic disease management significantly reduced fasting glucose by 1.68%, postprandial glucose by 3.4%, and HbA1c by 0.45%. High-compliance patients experienced greater reductions, including a 5.55% decrease in fasting glucose.

conclusionDigital health platforms effectively improve glycemic control, especially with high patient compliance, supporting their broader implementation in chronic disease management.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2TelemedicineAdultAgedBlood GlucoseChinaDelivery of Health Care, IntegratedDisease ManagementFemaleGlycated HemoglobinHumansMaleMiddle AgedPatient ComplianceBlood GlucoseGlycated HemoglobinChronic disease managementDiabetes patientsDigital health platform

Identifiers

PMID40301882
PMCPMC12042360

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.